- -

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

Mostrar el registro completo del ítem

Rossetti, P.; Ampudia Blasco, FJ.; Laguna Sanz, AJ.; Revert Tomás, A.; Vehí Casellas, J.; Ascaso, JF.; Bondía Company, J. (2012). Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial. Diabetes Technology & Therapeutics. 14(11):1043-1052. doi:10.1089/dia.2012.0145.

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/31150

Ficheros en el ítem

Metadatos del ítem

Título: Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial
Autor:
Entidad UPV: Universitat Politècnica de València. Departamento de Ingeniería de Sistemas y Automática - Departament d'Enginyeria de Sistemes i Automàtica
Universitat Politècnica de València. Instituto Universitario de Automática e Informática Industrial - Institut Universitari d'Automàtica i Informàtica Industrial
Fecha difusión:
Resumen:
[EN] Objective: Prandial insulin dosing is an empirical practice associated frequently with poor reproducibility in postprandial glucose response. Based on continuous glucose monitoring (CGM), a method for prandial insulin ...[+]
Derechos de uso: Reserva de todos los derechos
Fuente:
Diabetes Technology & Therapeutics. (issn: 1520-9156 ) (eissn: 1557-8593 )
DOI: 10.1089/dia.2012.0145
Editorial:
Mary Ann Liebert
Versión del editor: http://dx.doi.org/10.1089/dia.2012.0145
Código del Proyecto: info:eu-repo/grantAgreement/EC/FP7/252085
Descripción: This is a copy of an article published in the Diabetes Technology and Therapeutics © 2012 [copyright Mary Ann Liebert, Inc.]; Diabetes Technology and Therapeutics is available online at: http://online.liebertpub.com.
Patrocinador:
European Union Seventh Framework Programme 252085
Spanish Ministry of Science DPI2010-20764-C02-01
Spanish Ministry of Science DPI2011-28112-C04-01
Tipo: Artículo

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro completo del ítem